Enhanced short-term improvement of insulin response to a low-caloric diet in obese carriers the Gly482Ser variant of the PGC-1alpha gene.

[1]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[2]  J. Martínez,et al.  Energy-restricted diets based on a distinct food selection affecting the glycemic index induce different weight loss and oxidative response. , 2008, Clinical nutrition.

[3]  A. Martí,et al.  Interaction between genes and lifestyle factors on obesity , 2008, Proceedings of the Nutrition Society.

[4]  J. Martínez,et al.  Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight. , 2007, Metabolism: clinical and experimental.

[5]  A. Bhat,et al.  Interaction between the UCP2–866G/A, mtDNA 10398G/A and PGC1α p.Thr394Thr and p.Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population , 2007, Human Genetics.

[6]  M. Laakso,et al.  Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. , 2007, The Journal of clinical endocrinology and metabolism.

[7]  Ekta Rai,et al.  PGC-1α Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study , 2007, Human Genetics.

[8]  Jordi Salas-Salvadó,et al.  Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica , 2007 .

[9]  A. Bhat,et al.  PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study. , 2007, Human genetics.

[10]  M. Rubio,et al.  [SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria]. , 2007, Medicina clinica.

[11]  J. Martínez,et al.  Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-γ2 gene polymorphisms , 2006, British Journal of Nutrition.

[12]  J. Martínez,et al.  Different dietary strategies for weight loss in obesity: role of energy and macronutrient content , 2006, Nutrition Research Reviews.

[13]  J. Martínez,et al.  A role for fruit content in energy-restricted diets in improving antioxidant status in obese women during weight loss. , 2006, Nutrition.

[14]  Jong Eun Lee,et al.  The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss , 2006, International Journal of Obesity.

[15]  S. O’Rahilly,et al.  Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes , 2006, Diabetologia.

[16]  F. Leonetti,et al.  The Gly482Ser Missense Mutation of the Peroxisome Proliferator-Activated Receptor γ Coactivator-1α (PGC-1α) Gene Associates with Reduced Insulin Sensitivity in Normal and Glucose-Intolerant Obese Subjects , 2006, Disease markers.

[17]  J. Martínez,et al.  Validation of the Spanish version of the physical activity questionnaire used in the Nurses' Health Study and the Health Professionals' Follow-up Study , 2005, Public Health Nutrition.

[18]  J. Lachin.  A review of methods for futility stopping based on conditional power , 2005, Statistics in medicine.

[19]  U. Seedorf,et al.  A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short‐term diet , 2005, Clinical genetics.

[20]  M. Uusitupa.  Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: evidence from the Finnish Diabetes Prevention Study. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[21]  A. Goldberg,et al.  Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. , 2005, Biochimica et biophysica acta.

[22]  J. Martínez,et al.  Postprandial insulin response and mitochondrial oxidation in obese men nutritionally treated to lose weight , 2005, European Journal of Clinical Nutrition.

[23]  T. Jørgensen,et al.  Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) gene in Danish subjects with the metabolic syndrome , 2005 .

[24]  J. Douketis,et al.  Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. , 2005, Seminars in vascular medicine.

[25]  T. Jørgensen,et al.  Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. , 2005, Diabetes research and clinical practice.

[26]  D. Moller,et al.  Metabolic syndrome: a clinical and molecular perspective. , 2005, Annual review of medicine.

[27]  M. Laakso,et al.  Common polymorphisms of the PPAR-γ2 (Pro12Ala) and PGC-1α (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial , 2004, Diabetologia.

[28]  T. Ogihara,et al.  Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases. , 2004, Diabetes research and clinical practice.

[29]  F. Schick,et al.  The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. , 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[30]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3 , 2004, Nature Medicine.

[31]  P. O'Connell,et al.  Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. , 2004, American journal of human genetics.

[32]  T. Kunej,et al.  A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. , 2004, Folia biologica.

[33]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. , 2004, Nature medicine.

[34]  L. Heilbronn,et al.  308 Nco I polymorphism of tumour necrosis factor α in overweight Caucasians , 2003 .

[35]  O. Pedersen,et al.  A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. , 2003, Diabetes.

[36]  P. Puigserver,et al.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.

[37]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[38]  L. Heilbronn,et al.  -308 Nco I polymorphism of tumour necrosis factor alpha in overweight Caucasians. , 2003, Diabetes research and clinical practice.

[39]  T. Kadowaki,et al.  A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes , 2002, Diabetologia.

[40]  B. Paulweber,et al.  Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Gene Locus Associations With Obesity Indices in Middle-Aged Women , 2002 .

[41]  B. Paulweber,et al.  Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. , 2002, Diabetes.

[42]  P. Boutin,et al.  No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasians. , 2002, Diabetologia.

[43]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[44]  T. Hansen,et al.  Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus , 2001, Diabetologia.

[45]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[46]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[47]  L. Groop,et al.  Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins , 2000, Diabetologia.

[48]  J. Levine,et al.  Role of nonexercise activity thermogenesis in resistance to fat gain in humans. , 1999, Science.

[49]  M. Ehm,et al.  An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. , 1998, The Journal of clinical investigation.

[50]  C. R. Kahn,et al.  Genetics of non-insulin-dependent (type-II) diabetes mellitus. , 1996, Annual review of medicine.

[51]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.